Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1985-2-14
pubmed:abstractText
The reactivity of Leu 1/T101 monoclonal antibodies (MoAb) was studied in a series of 69 lymphomas with B cell differentiation and was correlated with other cell markers. A three step immunoperoxidase technique on frozen sections was used to test a panel of 20 MoAb: anti-human Ig (heavy and light chains), To 15 (Pan B cells), Leu 1, T101, Leu 4, Leu 3a, Leu 5, OKT 8, OKT 6, Leu 7, anti-CALLA (IOT 5), Leu 10, anti-HLA-DR, OKM 1 and anti-dendritic reticulum cells (R 4/23). T101/Leu 1 antigen was detected in 24 cases: CLL (11 of 11), diffuse centrocytic lymphomas (four of 11), follicular lymphomas (none of 12), follicular and diffuse lymphomas (seven of 10) and one unclassified low grade lymphoma. This antigen was observed in only one high grade malignant lymphoma. In follicular lymphomas, two results deserve attention: (1) T101+ lymphomas showed most frequently IgM+, IgD+ surface Ig. Inversely, T101 unreactive lymphomas displayed IgM+, IgD+ phenotype. (2) Tp67 antigen (T101, Leu 1) and CALLA (GP 100) were found to be mutually exclusive in these lymphomas. These results suggest that follicular lymphomas could be derived from two distinct germinal center cell populations: IgM+ Ig'D-, Calla+, Leu 1-/T101- and IgM+, IgD+, CALLA-, Leu+/T101+.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-157372, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6155425, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6156984, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6175588, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6193856, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6242881, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6338047, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6338896, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6344913, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6416075, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6605688, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6756733, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6790625, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6805534, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6967511, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6975352, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6977012, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-6993560, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-7015346, http://linkedlifedata.com/resource/pubmed/commentcorrection/6239721-7034809
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
631-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't